TMOD-31. NOVEL HETEROGENEOUS GLIOBLASTOMA MODELS TO OPTIMIZE HUMAN TUMORICIDAL NEURAL STEM CELL THERAPY

Tumor-homing neural stem cell (NSC) therapy is a promising new strategy that recently entered human patient testing for glioblastoma (GBM). The success of NSCs in the clinic will depend on their ability to overcome the heterogeneity and invasiveness of patient GBM, and the development of preclinical...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Satterlee, Andrew, Dunn, Denise, Hagler, Shaye, Lo, Donald, Hingtgen, Shawn
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2018
Konular:
Abstracts
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216681/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.1143
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller